SCHD underperformed the S&P 500 in 2025 but remains highly attractive due to its strong risk-reward profile and dividend ...

The highest dividend-paying stocks in the S&P 500 can be misleading. That's because, at first glance, these big dividends ...

Discover 14 "safer" S&P 500 dividend stocks with strong free cash flow for stable payouts. Learn how they may offer 27%-53% ...

A Wall Street maxim states, “Twenty percent of investors who want to make money are in stocks, while the other 80 percent who ...

It might seem counterintuitive to buy safe dividend stocks with “boring” underlying businesses when everyone else is scrambling to buy the hottest AI and tech stocks at any price. The latter strategy ...

Pfizer faces a $1 billion sales hit in 2025 from IRA reforms, flat EPS and revenue forecasts, and long-term risks tied to patent expirations.

Dividend-paying stocks have appeal to investors for a variety of reasons. This includes providing regular income and their ...

Penserra Capital Management significantly slashed its Pfizer holdings by 67%, selling nearly 15,800 shares, leaving a stake ...

Merck is tackling its looming “Keytruda cliff” with a bold $10 billion acquisition of Verona Pharma. The deal brings Ohtuvayre, a first-in-class COPD drug, into Merck’s portfolio as it looks to ...